Last reviewed · How we verify
NCT05858840: SUA
Urinary Artificial Sphincter in Children
trial testing Urinary Artificial Sphincter (UAS) in Children in Neurogenic Bladder in 17 participants. Completed in 10 April 2023.
31 January 2023
Quick facts
| Lead sponsor | University of Lorraine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 17 |
| Start date | 20 November 2022 |
| Primary completion | 31 January 2023 |
| Estimated completion | 10 April 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Urinary Artificial Sphincter (UAS) in Children
Conditions studied
- Neurogenic Bladder — all drugs for Neurogenic Bladder →
- Bladder Dysfunction — all drugs for Bladder Dysfunction →
- Spina Bifida — all drugs for Spina Bifida →
- Child, Only — all drugs for Child, Only →
Sponsor
University of Lorraine
Who can join
Under 17, any sex, with Neurogenic Bladder or Bladder Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective monocentric study of the outcomes of patients with neurogenic bladder, who had a urinary artificial sphincter before the age of 18 years old. Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05858840
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurogenic Bladder
Currently open trials in the same condition.
- NCT07308808 — Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation · EARLY_PHASE1 · recruiting
- NCT04187027 — Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele · NA · active not recruiting
- NCT04791579 — Antibiotic Prophylaxis for Neurogenic Bladder Botox · Phase 2 · recruiting
- NCT06515223 — Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury · NA · recruiting
- NCT06163469 — Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healt · NA · recruiting
Other University of Lorraine trials
Trials by the same sponsor.
- NCT07246382 — Evaluation of a Customizable Antibiotic Stewardship Program Tailored to French Nursing Homes · NA · not yet recruiting
- NCT06077097 — Traumatic Events in Childhood, Attachment, Pain Perception, Epigenetic Marks, Quality of Life and Resilience. · completed
- NCT05699980 — Prevalence and Comorbidities of Dermatoporosis: a French Prospective Observational Study in General Medicine Consultatio · completed
- NCT05843539 — Adverse Childhood Experiences, Adaptation and Breast Cancer · completed
- NCT06194240 — Contributions of Health Psychology to Support Patients With Diabetes Through Online Tools · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05858840 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lorraine
- Last refreshed: 16 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05858840.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing